Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 May;157(4):463-71.
doi: 10.1111/j.1365-2141.2012.09095.x. Epub 2012 Mar 13.

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial

Jonathan I Sive  1 , Georgina Buck, Adele Fielding, Hillard M Lazarus, Mark R Litzow, Selina Luger, David I Marks, Andrew McMillan, Anthony V Moorman, Susan M Richards, Jacob M Rowe, Martin S Tallman, Anthony H Goldstone
Affiliations
Clinical Trial

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial

Jonathan I Sive et al. Br J Haematol. 2012 May.

Abstract

Although the incidence rate of acute lymphoblastic leukaemia (ALL) is slightly higher in older than in younger adults, response rates to induction chemotherapy and survival rates are poorer. The contribution of disease-related versus treatment-related factors remains unclear. We analysed 100 older patients (aged 55-65 years) treated on the UKALLXII/ECOG2993 trial compared with 1814 younger patients (aged 14-54 years). Baseline characteristics, induction chemotherapy course, infections, drug reductions and survival outcomes were compared. There were more Philadelphia-positive (Ph+) patients in the older group (28% vs. 17%, P = 0·02), and a trend towards higher combined cytogenetic risk score (46% vs. 35%, P = 0·07). The complete remission rate in older patients was worse (73% vs. 93%, P < 0·0001) as was 5-year overall survival (21% vs. 41%, P < 0·0001) and event-free survival (EFS) (19% vs. 37%, P < 0·0001). Older patients had more infections during induction (81% vs. 70%, P = 0·05), and drug reductions (46% vs. 28%, P = 0·0009). Among older patients, Ph+ and cytogenetic risk category as well as infection during induction predicted for worse EFS. Poorer outcomes in these patients are partly due to cytogenetic risk, but there is significant morbidity and mortality during induction chemotherapy with frequent delays and drug reductions. New approaches, including better risk stratification and use of targeted therapies, could improve treatment for these patients.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Conflicts of Interest

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1
Survival of patients by age at entry to study showing (A) overall survival and (B) event free survival in all patients and (C) overall survival in just those who received chemotherapy.
Figure 2
Figure 2
Patient flow diagram showing outcomes following induction in all patients aged 55 years and over. aIncludes 3 without CR status recorded – presumed to be CR. bIncludes 1 alive 4 years post-autograft, then lost to follow-up cIncludes 2 patients lost to follow-up at 2.4 and 8.2 years
See this image and copyright information in PMC

References

    1. Annino L, Vegna ML, Camera A, et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood. 2002 Feb 1;99(3):863–71. - PubMed
    1. Appelbaum FR. Impact of age on the biology of acute leukemia. In: Perry MC, editor. American Society of Clinical Oncology Educational Book. 2005. pp. 528–532.
    1. DeAngelo DJ, Yu D, Johnson JL, et al. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. Blood. 2007 Jun 15;109(12):5136–42. - PMC - PubMed
    1. Fielding A, Buck G, Lazarus HM, et al. Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial. ASH Abstract. 2010:169.
    1. Gardner A, Mattiuzzi G, Faderl S. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol. 2008;26(35):5684–8. - PMC - PubMed

Publication types